310 related articles for article (PubMed ID: 34040179)
1. The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.
Davidson BA; Croessmann S; Park BH
Br J Cancer; 2021 Sep; 125(6):780-788. PubMed ID: 34040179
[TBL] [Abstract][Full Text] [Related]
2. Identification of circulating tumour DNA (ctDNA) from the liquid biopsy results: Findings from an observational cohort study.
Myint KZY; Shimabuku M; Horio R; Kaneda M; Shimizu Y; Taguchi J
Cancer Treat Res Commun; 2023; 35():100701. PubMed ID: 37094468
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing.
Ranghiero A; Frascarelli C; Cursano G; Pescia C; Ivanova M; Vacirca D; Rappa A; Taormina SV; Barberis M; Fusco N; Rocco EG; Venetis K
Cytopathology; 2023 Nov; 34(6):519-529. PubMed ID: 37640801
[TBL] [Abstract][Full Text] [Related]
4. Targeted mutation detection in breast cancer using MammaSeq™.
Smith NG; Gyanchandani R; Shah OS; Gurda GT; Lucas PC; Hartmaier RJ; Brufsky AM; Puhalla S; Bahreini A; Kota K; Wald AI; Nikiforov YE; Nikiforova MN; Oesterreich S; Lee AV
Breast Cancer Res; 2019 Feb; 21(1):22. PubMed ID: 30736836
[TBL] [Abstract][Full Text] [Related]
5. Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers.
Addanki S; Meas S; Sarli VN; Singh B; Lucci A
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887191
[TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
Zivanovic Bujak A; Weng CF; Silva MJ; Yeung M; Lo L; Ftouni S; Litchfield C; Ko YA; Kuykhoven K; Van Geelen C; Chandrashekar S; Dawson MA; Loi S; Wong SQ; Dawson SJ
PLoS Med; 2020 Oct; 17(10):e1003363. PubMed ID: 33001984
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor DNA: current challenges for clinical utility.
Dang DK; Park BH
J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35703177
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.
Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C
J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.
Croessmann S; Park BH
Clin Adv Hematol Oncol; 2021 Mar; 19(3):155-161. PubMed ID: 33739964
[TBL] [Abstract][Full Text] [Related]
11. Application of circulating tumor DNA in breast cancer.
Zhao Y; Sheng M; Zheng L; Xiong D; Yang K; Luo Y
Breast J; 2020 Sep; 26(9):1797-1800. PubMed ID: 32052544
[TBL] [Abstract][Full Text] [Related]
12. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
[TBL] [Abstract][Full Text] [Related]
13. [Liquid biopsy in colorectal cancer : An overview of ctDNA analysis in tumour diagnostics].
Haupts A; Roth W; Hartmann N
Pathologe; 2019 Dec; 40(Suppl 3):244-251. PubMed ID: 31797045
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal Cancer.
van 't Erve I; Greuter MJE; Bolhuis K; Vessies DCL; Leal A; Vink GR; van den Broek D; Velculescu VE; Punt CJA; Meijer GA; Coupé VMH; Fijneman RJA
J Mol Diagn; 2020 Dec; 22(12):1430-1437. PubMed ID: 32961317
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor DNA in Breast Cancer: Current and Future Applications.
Medford AJ; Denault EN; Moy B; Parsons HA; Bardia A
Clin Breast Cancer; 2023 Oct; 23(7):687-692. PubMed ID: 37438196
[TBL] [Abstract][Full Text] [Related]
16. Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer.
Chin YM; Takahashi Y; Chan HT; Otaki M; Fujishima M; Shibayama T; Miki Y; Ueno T; Nakamura Y; Low SK
Cancer Sci; 2021 Jan; 112(1):454-464. PubMed ID: 33075187
[TBL] [Abstract][Full Text] [Related]
17. Liquid Biopsies for Monitoring Temporal Genomic Heterogeneity in Breast and Colon Cancers.
Venesio T; Siravegna G; Bardelli A; Sapino A
Pathobiology; 2018; 85(1-2):146-154. PubMed ID: 28614831
[TBL] [Abstract][Full Text] [Related]
18. Liquid Biopsy in Endometrial Cancer: New Opportunities for Personalized Oncology.
Muinelo-Romay L; Casas-Arozamena C; Abal M
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30087246
[TBL] [Abstract][Full Text] [Related]
19. Circulating Tumor DNA in the Management of Early-Stage Breast Cancer.
Vlataki K; Antonouli S; Kalyvioti C; Lampri E; Kamina S; Mauri D; Harissis HV; Magklara A
Cells; 2023 Jun; 12(12):. PubMed ID: 37371043
[TBL] [Abstract][Full Text] [Related]
20. Plasma DNA as a "liquid biopsy" incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer.
Chamberlin MD; Wells JD; Shee K; Bean JR; Marotti JD; Wells WA; Trask HW; Kolling FW; Bhatt A; Kaufman PA; Schwartz GN; Gemery JM; McNulty NJ; Tsapakos MJ; Barth RJ; Arrick BA; Gui J; Miller TW
Breast Cancer Res Treat; 2020 Aug; 182(3):665-677. PubMed ID: 32562118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]